文献速递关节外科

2019 John Charnley 奖:初次全膝与全髋关节置换术使用非头孢唑林抗生素预防时假体周围感染风险增加:抗生素过敏检测对预防用药的价值

2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis.
PubMed 文献 · Bone Joint J · 2019-01-01

该研究在单一学术机构纳入2004年1月至2017年5月间初次全膝或全髋关节置换术29695例(22705例患者),其中2576例患者(11.5%,3411例关节)术前接受抗生素过敏检测,97%被确认可使用头孢菌素。全队列94.9%使用头孢唑林,5.1%使用非头孢唑林抗生素;调整ASA分级、关节类型和BMI后,头孢唑林组假体周围感染风险低32%(p<0.001)。作者推荐对青霉素和头孢菌素过敏患者进行围手术期检测与清除。

要点

  • 2576例过敏检测患者中2493例(97%)被确认可使用头孢菌素。
  • 全队列94.9%使用头孢唑林,5.1%使用非头孢唑林抗生素。
  • 调整ASA分级、关节类型和BMI后,头孢唑林组假体周围感染风险低32%(p<0.001)。

核心结论

  • 使用非头孢唑林抗生素进行围手术期预防时假体周围感染率显著更高,术前抗生素过敏检测提高头孢唑林使用率具有正面影响。
  • 鉴于真性青霉素过敏阳性率低且抗生素选择是易于改变的风险因素,作者推荐对所有青霉素和头孢菌素过敏患者进行围手术期检测与清除。

研究设计与样本

  • 单一学术机构2004年1月至2017年5月间所有初次全膝或全髋关节置换术的评估,共29695例关节(22705例患者)。
  • 其中2576例患者(11.5%)的3411例关节术前接受过敏检测。
  • 联合多个机构数据库识别过敏会诊结果、围手术期抗生素方案及至末次随访的无感染生存。

主要发现

  • 2576例过敏检测患者中2493例(97%)被确认可使用头孢菌素。
  • 全队列28174例关节(94.9%)接受头孢唑林,1521例(5.1%)接受非头孢唑林抗生素。
  • 头孢唑林组无感染生存显著高于非头孢唑林组:1个月高0.06%、2个月高0.56%、1年高0.61%、10年高1.19%(p<0.001)。
  • 调整ASA分级、关节置换类型(全膝或全髋)和BMI后,头孢唑林组假体周围感染风险低32%(p<0.001)。
  • 预防1例假体周围感染需用头孢唑林治疗的人数:1年为164例患者,10年为84例患者;在100万例初次全膝和全髋关节置换患者队列中,1年或可预防6098例假体周围感染,10年或可预防11905例。

关键数值与推荐

  • 头孢唑林组较非头孢唑林组无感染生存1个月高0.06%、2个月高0.56%、1年高0.61%、10年高1.19%(p<0.001)。
  • 调整ASA分级、关节类型和BMI后,头孢唑林组假体周围感染风险低32%(p<0.001)。
  • 预防1例假体周围感染需用头孢唑林治疗的人数:1年164例患者,10年84例患者。

临床怎么用

  • 作者推荐对所有青霉素和头孢菌素过敏患者进行围手术期检测与清除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aims of this study were to characterize antibiotic choices for perioperative total knee arthroplasty (TKA) and total hip arthroplasty (THA) prophylaxis, assess antibiotic allergy testing efficacy, and determine rates of prosthetic joint infection (PJI) based on perioperative antibiotic regimen. PATIENTS AND METHODS: We evaluated all patients undergoing primary TKA or THA at a single academic institution between January 2004 and May 2017, yielding 29 695 arthroplasties (22 705 patients), with 3411 arthroplasties in 2576 patients (11.5%) having undergone preoperative allergy testing. A series of institutional databases were combined to identify allergy consultation outcomes, perioperative antibiotic regimen, and infection-free survivorship until final follow-up. RESULTS: Among 2576 allergy-tested patients, 2493 patients (97%) were cleared to use cephalosporins. For the entire cohort, 28 174 arthroplasties (94.9%) received cefazolin and 1521 (5.1%) received non-cefazolin antibiotics. Infection-free survivorship was significantly higher among arthroplasties receiving cefazolin compared with non-cefazolin antibiotics, with 0.06% higher survival free of infection at one month, 0.56% at two months, 0.61% at one year, and 1.19% at ten years (p < 0.001). Overall, the risk of PJI was 32% lower in patients treated with cefazolin after adjusting for the American Society of Anesthesiologists (ASA) classification, joint arthroplasty (TKA or THA), and body mass index (BMI; p < 0.001). The number needed to treat with cefazolin to prevent one PJI was 164 patients at one year and 84 patients at ten years. Therefore, potentially 6098 PJIs could be prevented by one year and 11 905 by ten years in a cohort of 1 000 000 primary TKA and THA patients. CONCLUSION: PJI rates are significantly higher when non-cefazolin antibiotics are used for perioperative TKA and THA prophylaxis, highlighting the positive impact of preoperative antibiotic allergy testing to increase cefazolin usage. Given the low rate of true penicillin allergy positivity, and the readily modifiable risk factor that antibiotic choice provides, we recommend perioperative testing and clearance for all patients presenting with penicillin and cephalosporin allergies. Cite this article: Bone Joint J 2019;101-B(6 Supple B):9-15.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Wyles CC, Hevesi M, Osmon DR, et al. 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis. Bone Joint J. 2019. PMID: 31146571. doi:10.1302/0301-620X.101B6.BJJ-2018-1407.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。